4AB.DE · ABBVIE INC. DL-,01
Germany · RS rating 93 · As of 2026-10-14
| Price | 253.90 EUR |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 90 / 80 / 77 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 59 / 58 / 97 |
| Industry group (rank) | Medical-Ethical Drugs (–) |
| EPS growth Q/Q | +420.5% |
| Sales growth Q/Q | +13.2% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $485.2B |